Targeting miR-21 decreases expression of multi-drug resistant genes and promotes chemosensitivity of renal carcinoma.
Gaudelot, Kelly; Gibier, Jean-Baptiste; Pottier, Nicolas; Hémon, Brigitte; Van Seuningen, Isabelle; Glowacki, François; Leroy, Xavier; Cauffiez, Christelle; Gnemmi, Viviane; Aubert, Sébastien; Perrais, Michaël.
; 39(7): 1010428317707372, 2017 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-28714373
Heavy Metal Enlightens Tumor Immunity.
SnapShot: Renal Cell Carcinoma.
Seeing the forest for the trees: kidney oncogenomes in relation to therapeutic outcomes.
Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor.
Diagnostic and prognostic value of scavenger receptor class B type 1 in clear cell renal cell carcinoma.
Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy.
A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma.
The G-protein-coupled receptor CLR is upregulated in an autocrine loop with adrenomedullin in clear cell renal cell carcinoma and associated with poor prognosis.
Downregulation of miR-193a-3p inhibits cell growth and migration in renal cell carcinoma by targeting PTEN.
High grade infiltrative adenocarcinomas of renal cell origin: New insights into classification, morphology, and molecular pathogenesis.